Name: Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors
Start: 2025-01-30T13:00:00-05:00
End: 2025-01-30T14:00:00-05:00
Location: Virtual Event

Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors

January 30 @ 1:00 pm - 2:00 pm

Join this webinar to learn about the role of IDH inhibitors in brain tumor care and explore the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib.

In this Webinar, you will:

Understand what IDH inhibitors are and how they are diagnosed
Learn about how IDH inhibitors influence treatment decisions
Recognize the role of IDH inhibitors in treatment advancements and patient outcomes
Q&A with presenter

Presenter: John de Groot, MD

Dr. John de Groot is a neuro-oncologist who specializes in diagnosing and managing the care of patients with primary brain and spine tumors.

This webinar will have Spanish subtitles available.
Este seminario de web tendrá subtítulos en español.